BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27664396)

  • 1. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
    Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
    J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [
    de Laat B; Kling YE; Schroyen G; Ooms M; Hooker JM; Bormans G; Van Laere K; Ceccarini J
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):492-502. PubMed ID: 34142214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging.
    Van Laere K; Ahmad RU; Hudyana H; Celen S; Dubois K; Schmidt ME; Bormans G; Koole M
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):254-61. PubMed ID: 23160998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
    Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
    Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects.
    Delnomdedieu M; Forsberg A; Ogden A; Fazio P; Yu CR; Stenkrona P; Duvvuri S; David W; Al-Tawil N; Vitolo OV; Amini N; Nag S; Halldin C; Varrone A
    Neuropharmacology; 2017 May; 117():171-181. PubMed ID: 28122201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.
    Ooms M; Rietjens R; Rangarajan JR; Vunckx K; Valdeolivas S; Maes F; Himmelreich U; Fernandez-Ruiz J; Bormans G; Van Laere K; Casteels C
    Neurobiol Aging; 2014 Dec; 35(12):2858-2869. PubMed ID: 25018107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis and biological evaluation of the new PDE10A radioligand [
    Wagner S; Teodoro R; Deuther-Conrad W; Kranz M; Scheunemann M; Fischer S; Wenzel B; Egerland U; Hoefgen N; Steinbach J; Brust P
    J Labelled Comp Radiopharm; 2017 Jan; 60(1):36-48. PubMed ID: 27896836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 10A in the rat pineal gland: localization, daily and seasonal regulation of expression and influence on signal transduction.
    Spiwoks-Becker I; Wolloscheck T; Rickes O; Kelleher DK; Rohleder N; Weyer V; Spessert R
    Neuroendocrinology; 2011; 94(2):113-23. PubMed ID: 21474921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
    Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
    Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
    Russwurm C; Koesling D; Russwurm M
    J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.